Taketo Kawai

Teikyo University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Medical Imaging Medical Imaging professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Tomoyuki Kaneko

Teikyo University

JAPAN

View details

Kazuma Sugimoto

University of Tokyo Hospital

JAPAN

View details

Sebastiano Buti

ITALY

View details

Tohru Nakagawa

JAPAN

View details

Yukari Uemura

Section Chief

National Center For Global Health and Medicine

JAPAN

View details

Masaki Shiota

Kyushu University

JAPAN

View details

Yusuke Sugino

Mie university

JAPAN

View details

Kiyoaki Nishihara

Kurume University

JAPAN

View details

Motofumi Suzuki

Chief director

JAPAN

View details

Melissa Bersanelli

Adjunct Professor in Medical Oncology

University of Parma

ITALY

View details

Hidenori Sakanashi

National Institute of Advanced Industrial Science and Technology (AIST)

JAPAN

View details

Keita Kobayashi

Yamaguchi University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Taketo Kawai

Research Interests

Explore related searches

Contact this professor

Articles (27)

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study

Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinoma

Local therapy for oligometastatic prostate cancer

The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study

Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma

Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis

Vesicovaginal fistula and bladder calculus formation secondary to long‐term retention of an intrauterine device

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer

Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional study

Photodynamic diagnosis‐assisted transurethral resection of bladder tumor for high‐risk non‐muscle invasive bladder cancer improves intravesical recurrence‐free survival (BRIGHT study)

Is there a role for pembrolizumab beyond progression in urothelial carcinoma?

Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma

Lower pretreatment serum testosterone level predicts poor prognosis in the patients with metastatic hormone-sensitive prostate cancer undergoing androgen deprivation therapy

Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative review

Efficacy and safety of intravesical dimethyl sulfoxide treatment for patients with refractory Hunner‐type interstitial cystitis: Real‐world data postofficial approval in Japan

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab

Predictive Factors of Lower Urinary Tract Injuries and Spontaneous Voiding Failure After Pelvic Fractures.

Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients.

Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.

Deep Learning Models for Cystoscopic Recognition of Hunner Lesion in Interstitial Cystitis.

Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma.

Preservation of pelvic floor muscles contributes to early continence recovery after robot-assisted radical prostatectomy.

The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy.

Primary diffuse large B cell lymphoma of the prostate in a patient with HIV infection.

Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer.

Collaborators (12)

Tomoyuki Kaneko

Kazuma Sugimoto

Sebastiano Buti

Tohru Nakagawa

Yukari Uemura

Masaki Shiota

Yusuke Sugino

Kiyoaki Nishihara

Motofumi Suzuki

Melissa Bersanelli

Hidenori Sakanashi

Keita Kobayashi

Make your next move.